SHANNA CIPRO: Open Payments
NPI 1093587164 · ORLEANS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $197 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $195 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Soleno Therapeutics, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: COBENFY, REXULTI, INVEGA SUSTENNA, UZEDY, CAPLYTA, FANAPT, VYKAT XR, Jornay PM.
Industry payments across MA — which companies pay providers there.
